Globus Pharyngeus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients aged between 18 and 75 years; 2.Patients diagnosed with Globus Pharyngeus (GP) based on clinical symptoms and necessary examinations; 3.A score of 6 or higher on the Laryngopharyngeal Measure of Perceived Sensation (LUMP); 4.Patients willing to undergo transaural vagus nerve stimulation (taVNS) treatment and capable of adhering to the study protocol and requirements; 5.Patients who have fully understood the study details and voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Presence of other serious medical conditions that may affect study outcomes or patient safety, such as severe cardiac disease, psychiatric disorders, or neurological diseases; 2.Patients with implanted medical devices, including pacemakers, neural stimulators, or other electronic medical devices; 3.Ear diseases: Individuals suffering from conditions such as otitis media or external otitis, which may interfere with the administration of taVNS treatment; 4.Medication use: Patients currently undergoing pharmacological treatments that could affect the symptoms of Globus Pharyngeus (GP), who are unwilling to pause these medications during the study period; 5.Pregnancy or breastfeeding: Women who are currently pregnant or breastfeeding; 6.Recent participation in other clinical trials: Patients who have participated in another clinical trial within the past three months; 7.Language or cognitive impairments: Patients with language comprehension or cognitive impairments that prevent them from understanding study requirements or independently completing questionnaires; 8.History of allergies or adverse reactions to electrical stimulation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Laryngopharyngeal Measure of Perceived Sensation (LUMP) ; | — |
Secondary
| Measure | Time frame |
|---|---|
| SAS;SDS; | — |
Countries
China
Contacts
Wuxi Huishan District People’s Hospital